Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jon Kroll Bjerregaard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
Petersen, P. C., Petersen, L. N., Vogelius, I., Bjerregaard, J. K. & Baeksgaard, L., Jul 2021, In: Acta Oncologica. 60, 7, p. 948-953 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
EP1.08-07 Correlation Between Genetic Profiling and Response in Danish ALK-Positive NSCLC Patients Treated with Crizotinib
Melchior, L. C., Santoni-Rugiu, E., Sørensen, J. B., Bjerregaard, J. K. & Urbanska, E., Oct 2019.Research output: Contribution to conference › Poster › Research › peer-review